Hikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USP

[In The News]

LONDON, May 1, 2019 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody's / BB+ S&P, both stable) the multinational pharmaceutical company, today launched its 100th injectable medicine in the United States with the...

View the full article